Treatment with an Anti-CD44v10-Specific Antibody Inhibits the Onset of Alopecia Areata in C3H/HeJ Mice
- 1 October 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (4), 653-657
- https://doi.org/10.1046/j.1523-1747.2000.00113.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Successful Treatment of Alopecia Areata-Like Hair Loss with the Contact Sensitizer Squaric Acid Dibutylester (SADBE) in C3H/HeJ MiceJournal of Investigative Dermatology, 1999
- Experimental Induction of Alopecia Areata-Like Hair Loss in C3H/HeJ Mice Using Full-Thickness Skin GraftsJournal of Investigative Dermatology, 1998
- Predominant Expression of CD44 Splice Variant v10 in Malignant and Reactive Human Skin LymphocytesJournal of Investigative Dermatology, 1998
- Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptideMultiple Sclerosis Journal, 1998
- Autoantibodies to Hair Follicles in C3H/HeJ Mice With Alopecia Areata–Like Hair LossJournal of Investigative Dermatology, 1997
- In vivodepletion of CD8+T cells restores hair growth in the DEBR model for alopecia areataBritish Journal of Dermatology, 1996
- Administration of Antibodies to Hyaluronanreceptor (CD44) Delays the Start and Ameliorates the Severity of Collagen II ArthritisScandinavian Journal of Immunology, 1995
- Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtisNature Medicine, 1995
- Alopecia Areata: An Immunologic Disease?Journal of Investigative Dermatology, 1991
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986